2019-11-15T14:56:49-06:00 2018-12-31 GRANT THORNTON LLP 2001 MARKET STREET SUITE 700 PHILADELPHIA PA 19103 990 2018-01-01 237311318 Drug Information Association Inc % JOY WHITLOW DRUG 2154426100 21 Dupont Circle NW Suite 300 Washington DC 20036 JOY WHITLOW cfo 2154426126 2019-11-14 true Russleee Armstrong P00288383 2155614200 65.229.27.130 23695320193195000116 2019-11-15 P 5ECDBAAA2251BF06823C096906AB0990A13F2727 5ECDBAAA2251BF06823C096906AB0990A13F2727 2018 2020-03-31 21:24:44Z Barbara Lopez Kunz 21 Dupont Circle NW Suite 300 Washington DC 20036 30943293 false X www.diaglobal.org X 1964 MD Attachment 1 13 13 58 2468 255256 41676 0 0 22171029 23320631 356217 270389 135370 23017 22662616 23614037 0 2400 0 0 9820087 10041667 0 0 0 13273006 13412666 23093093 23456733 -430477 157304 17045730 14815950 10432453 8958495 6613277 5857455 X DRUG INFORMATION ASSOCIATION, INC. ("DIA") FOSTERS INNOVATION TO IMPROVE HEALTH AND WELLBEING WORLDWIDE BY: - PROVIDING INVALUABLE FORUMS TO EXCHANGE VITAL INFORMATION AND DISCUSS CURRENT ISSUES RELATED TO HEALTH PRODUCTS, TECHNOLOGIES, AND SERVICES; - DELIVERING CUSTOMIZED LEARNING EXPERIENCES; - BUILDING, MAINTAINING, AND FACILITATING TRUSTED RELATIONSHIPS WITH AND AMONG INDIVIDUALS AND ORGANIZATIONS THAT DRIVE AND SHARE DIA VALUES AND MANDATES; AND - OFFERING A MULTIDISCIPLINARY NEUTRAL ENVIRONMENT, RESPECTED GLOBALLY FOR INTEGRITY AND RELEVANCY. false false 6450792 18624234 MEETING AND WORKSHOPS: THE NUMBER OF MEETINGS AND WORKSHOPS HELD HAS INCREASED FROM A TOTAL OF TWO EVENTS HELD IN THE UNITED STATES IN 1980, TO A TOTAL OF 305 EVENTS HELD WORLDWIDE IN 2018. IN 2018, DIA CONDUCTED 110 WORKSHOPS AND TRAINING COURSES IN THE UNITED STATES WITH OVER 4,000 PARTICIPANTS. IN ADDITION TO THESE EVENTS, THE DIA ANNUAL MEETING, THE LEADING GLOBAL CONFERENCE ON PHARMACEUTICAL INFORMATION AND EDUCATION, ATTRACTED 6,900 PARTICIPANTS FROM THE US AND ACROSS THE WORLD. IN 2018, DIA CONDUCTED 95 WORKSHOPS AND TRAINING COURSES ACROSS EUROPE, ATTRACTING OVER 3,500 PARTICIPANTS. IN ADDITION, THE ANNUAL DIA EURO MEETING, WHICH ATTRACTED OVER 1,000 PARTICIPANTS, IS RECOGNIZED AS ONE OF THE PREMIER FORUMS FOR EXCHANGE OF INFORMATION IN THE EUROPEAN MEDICAL/PHARMACEUTICAL COMMUNITY. IN 2018, DIA CONDUCTED 24 EDUCATIONAL EVENTS IN JAPAN, ATTRACTING OVER 3,400 PARTICIPANTS FROM JAPAN AND OTHER COUNTRIES. IN 2018, DIA CONDUCTED 14 EVENTS IN CHINA, ATTRACTING OVER 5,400 PARTICIPANTS. IN 2018, DIA CONDUCTED 8 EVENTS IN INDIA, ATTRACTING OVER 500 PARTICIPANTS. IN 2018, DIA CONDUCTED 7 EVENTS IN REST OF THE WORLD, ATTRACTING 400 PARTICIPANTS. WITH AN ON-GOING COMMITMENT TO INTERNET TECHNOLOGY-BASED LEARNING, DIA CONTINUED TO EXPAND ITS GLOBAL REACH AND ADVANCE ITS MISSION BY OFFERING VARIOUS WORKSHOPS IN ELECTRONIC WEBINAR FORMAT. IN 2018, DIA CONDUCTED 46 WEBINARS, ATTRACTING OVER 2,200 INDIVIDUAL AND GROUP PARTICIPANTS. 1275217 3407261 TRAINING: IN 2018, DIA CONDUCTED 203 TRAINING COURSES ACROSS THE GLOBE. WITH AN ON-GOING COMMITMENT TO INTERNET TECHNOLOGY-BASED LEARNING, DIA CONTINUED TO EXPAND ITS GLOBAL REACH AND ADVANCE ITS MISSION BY OFFERING VARIOUS WORKSHOPS IN ELECTRONIC WEBINAR FORMAT. IN 2018, DIA CONDUCTED 40 WEBINARS, 4 GLOBAL CUSTOMIZED TRAININGS AND 46 E-LEARNING MODULES 169144 356972 PUBLICATIONS: THERAPEUTIC INNOVATION & REGULATORY SCIENCE PUBLICATION (TIRS) IS THE OFFICIAL JOURNAL OF DIA. ITS MISSION IS TO ADVANCE HEALTHCARE PRODUCT DISCOVERY, DEVELOPMENT, REGULATION, AND USE THROUGH THE PUBLICATION OF PEER-REVIEWED ARTICLES AND COMMENTARIES ACROSS THE SPECTRUM OF CONVERTING BIOMEDICAL SCIENCE INTO PRACTICAL SOLUTIONS TO ADVANCE HUMAN HEALTH. IT IS PUBLISHED IN ODD NUMBER MONTHS, JANUARY, MARCH, MAY, JULY, SEPTEMBER, AND NOVEMBER. DIA ALSO PUBLISHES THE GLOBAL FORUM, ANOTHER E-PUBLICATION. IT OFFERS EXPERT GLOBAL AND REGIONAL COVERAGE OF DISCOVERY, DEVELOPMENT, REGULATION, SURVEILLANCE, AND MARKETING OF HEALTHCARE PRODUCTS, INCLUDING INTERVIEWS WITH LEADERS AND TOPICAL SUMMARIES FROM EDUCATIONAL EVENTS. IT IS PUBLISHED BI-MONTHLY ALTERNATING TO THE TIRS. 13508904 2400 932164 All other program service expenses 13508904 2400 932164 21404057 true false false false false false false false false false true false false true false true false true false true true false false false false false false false false true false false false false false false false false false false false false true true true true false false true 85 0 true 58 true true true true CH IN JA SZ false false false false false false false false false false X 13 13 false false false false true true true true true false true true true true true true true true true true false X JOY WHITLOW 2154426126 800 ENTERPRISE ROAD SUITE 200 Horsham PA 19044 Joseph Scheeren CHAIR 2.5 0.0 X X 0 0 0 Rebecca A Vermeulen Chair-Elect 2.5 0.0 X X 0 0 0 Jeffrey S Payne Secretary/TREASURER 2.5 0.0 X X 0 0 0 GESINE BEJEUHR PhD MEMBER (End 6/2018) 1.25 0.0 X 0 0 0 ANDRZEJ CZARNECKI MD PhDDSc MEMBER 1.25 0.0 X 0 0 0 ANGELIKA JOOS MEMBER 1.25 0.0 X 0 0 0 MICHELLE McMURRY-HEATH MDPhD MEMBER (End 6/2018) 1.25 0.0 X 0 0 0 JUDITH NG-CASHIN MEMBER 1.25 0.0 X 0 0 0 MICHAEL ROSENBLATT MEMBER 1.25 0.0 X 0 0 0 Jonathan Sheldon MEMBER 1.25 0.0 X 0 0 0 Lingshi Tan MEMBER 1.25 0.0 X 0 0 0 JOHN A ROBERTS MBA MEMBER 1.25 0.0 X 0 0 0 Michael Romano MEMBER 1.25 0.0 X 0 0 0 Kihito Takahashi MEMBER 1.25 0.0 X 0 0 0 Cynthia L Verst Member 1.25 0.0 X 0 0 0 BARBARA LOPEZ KUNZ MSC GLOBAL CHIEF EXECUTIVE 37.5 0.0 X 699294 0 47218 BAYARD GARDINEER CFO/WORLDWIDE DIR. OF FINANCE 37.5 0.0 X 295164 0 29064 Sudip Parikh Sr. VP/ MNG DIR. DIA Americas 37.5 0.0 X 424694 0 43385 THOMAS BOLS SVP/MANAGING DIRECTOR-EMEA 40.0 0.0 X 307200 0 19476 Carol Zhu SVP/Managing Director-China 40.0 0.0 X 297828 0 13463 TIM HESS GLOBAL IT DIRECTOR 37.5 0.0 X 231495 0 12424 ELISABETH SVENSSON SVP, MARKETING 40.0 0.0 X 296880 0 21289 Ozgur Kara Associate Director, EMEA Finan 40.0 0.0 X 180236 0 14966 Cathy Persidis Associate Director, EMEA Opera 40.0 0.0 X 155381 0 11285 Akio Uemura SVP/Managing Director-Japan 40.0 0.0 X 150388 0 11098 Alexander Eldridge IT Project Manager 37.5 0.0 X 149720 0 8628 3188280 0 232296 18 false true false MCH MESSE SCHWEIZ BASEL MESSEPLATZ 10 BASEL 0 SZ 4005 Conf. Goods/Services 615301 LEVY RESTAURANTS 415 SUMMER STREET BOSTON MA 02210 Food services 503683 BETHESDA NORTH-MARRIOTT HOTEL PO BOX 402642 ATLANTA GA 30384 conf. goods/services 433193 AV EXPERIENCE 825 43E AVE LACHINE QUEBEC CA H8T 2J6 AUDIO VISUAL 394038 JSpargo Associates Inc 11208 Waples Mill Road Suite 112 FAIRFAX VA 22030 Exhibit Mgmt Service 352795 23 0 MEETINGS AND WORKSHOPS 611710 18624234 18624234 TRAINING 611710 3407261 3407261 MEMBERSHIP DUES 900099 932164 932164 PUBLICATIONS 900004 356972 101716 255256 23320631 206315 206315 0 0 148951 99549 49402 0 49402 49402 2127139 5166642 1913299 5316408 213840 -149766 64074 64074 0 0 0 0 0 0 0 0 0 FOREIGN CURRENCY TRANSLATION (LOSS) 900099 -26385 -26385 -26385 23614037 23065375 255256 293406 0 2400 2400 0 0 2109413 1767602 341811 0 6403773 5908651 495122 316986 300320 16666 604397 546152 58245 607098 559801 47297 0 359075 273560 85515 99545 74764 24781 0 0 70331 52045 18286 918141 727265 190876 313792 260664 53128 178564 146403 32161 361735 283420 78315 0 1158773 923267 235506 710498 571958 138540 0 6450792 6450792 18620 13788 4832 0 262969 238004 24965 98359 73498 24861 TRAINING EXPENSES 1275217 1275217 DUES AND SUBSCRIPTIONS 783793 614755 169038 PUBLICATIONS 169144 169144 0 MEMBERSHIP DEVELOPMENT 92233 92233 0 91085 78354 12731 23456733 21404057 2052676 0 0 0 4104279 4222039 0 0 684229 354049 0 0 0 0 0 0 0 0 866754 1448805 3544513 2767368 5404970 777145 5313687 6978627 0 0 0 0 0 0 671811 1035285 17045730 14815950 3296816 3448539 0 0 5055779 5509956 0 0 0 0 0 0 0 0 2007868 0 71990 0 10432453 8958495 X 6613277 5857455 0 0 0 0 6613277 5857455 17045730 14815950 X 157304 -1024110 110984 X false true X true false X 0 0 0 0 0 0 22517090 22049411 21572283 22171029 23320631 111630444 0 0 0 22517090 22049411 21572283 22171029 23320631 111630444 0 0 0 111630444 921458 700173 790575 792626 355266 3560098 72906 55708 14871 32924 176409 921458 773079 846283 807497 388190 3736507 -36060 -65321 -31338 -74607 -26385 -233711 8443 8000 0 0 0 16443 23410931 22765169 22387228 22903919 23682436 115149683 0.96944 0.96058 0.03245 0.04071 X 224310 141895 82415 2892155 2255152 637003 428048 370321 57727 777145 0 0 X 27717565 -1024110 5127638 4103528 23614037 23614037 28473387 5019054 5019054 23454333 2400 2400 23456733 ASC 740 (FIN48) Footnote SCHEDULE D, PART X, LINE 2 DIA is a U.S. entity exempt from federal income taxes under Section 501(c)(3) of the U.S. Internal Revenue Code and is a nontaxable membership association under Swiss law. DIA, LLC (Japan) (a Pennsylvania limited liability company) is disregarded as separate from DIA for income tax purposes in the U.S., however, its activities are subject to income tax in Japan. DIA India Private Limited (India) was established in and is subject to income tax in India. DIA Europe GmbH and DIA e-learning GmbH were established as tax-exempt entities in Switzerland and are exempt from income tax in Switzerland. DIA Global Healthcare, LLC (a Pennsylvania limited liability company) was established in 2011 and is disregarded as separate from DIA for income tax purposes in the U.S. DIA Beijing was established in 2012 and is subject to income tax in China. DIA Shanghai is subject to Income tax in China. SH DIA Japan was established in 2012 and is subject to income tax in Japan. DIA Learning, LLC (a Pennsylvania limited liability company) was established in 2015 and is disregarded as separate from DIA for U.S. income tax purposes.. Management monitors the Associations activities and considers the potential for income taxes when activities are not related to its exempt purpose. These activities, including advertising income and rental income, may be subject to federal income taxes. The Association did not have material net operating income from these activities in 2018 or 2017. The Association recognizes or derecognizes a tax position based on a more likely than not threshold. This applies to positions taken or expected to be taken in a tax return. The Association does not believe its consolidated financial statements include any material uncertain tax positions. Any interest and penalties, if applicable, would be recorded in administrative expenses. The Association is no longer subject to U.S. federal and state tax examinations for years prior to the year ended December 31, 2015. The Associations income tax filings in India for 2015 through 2018 are subject to examination by Indian tax authorities, and income tax filings in Japan for 2011 through 2018 are subject to examination by Japanese tax authorities. SH DIA Japan income tax filings are subject to examination by Japanese tax authorities for 2017 and 2018. DIA Beijing income tax filings are subject to examination by Chinese tax authorities for 2016, 2017 and 2018 and DIA Shanghai for 2018. Should settlement of an examination or other event result in a change in managements evaluation of a tax position taken or expected to be taken in filings that have not been closed by statute or examination, interest and penalties related to the unrecognized tax liability as a result of the uncertain tax position will be included in operating expenses. RECONCILIATION OF REVENUE SCHEDULE D, PART XI, LINE 2D SUBSIDIARIES REVENUE $5,028,089 Rental Expense $ 99,549 ------------ TOTAL $5,127,638 RECONCILIATION OF EXPENSES SCHEDULE D, PART XII, LINE 2D SUBSIDIARIES EXPENSE $4,919,505 Rental Expense $ 99,549 ------------ TOTAL $5,019,054 SCHEDULE D, PART XII, LINE 4b Patient Fellow Scholarship Grant $2,400 Europe (Including Iceland and Greenland) 1 19 Program Services Meetings & Training 5735935 East Asia and the Pacific 3 15 Program Services Meetings & Training 4755565 South Asia 1 3 Program Services Meetings & Training 157436 5 37 5 37 10648936 10648936 No grants given in 2017 true false true false false true X X X X false false false false false false false true false BARBARA LOPEZ KUNZ MSC GLOBAL CHIEF EXECUTIVE 522075 0 177219 0 0 0 31604 0 15614 0 746512 0 0 0 BAYARD GARDINEER CFO/WORLDWIDE DIR. OF FINANCE 234609 0 60555 0 0 0 14073 0 14991 0 324228 0 0 0 Sudip Parikh Sr. VP/ MNG DIR. DIA Americas 336259 0 88435 0 0 0 20808 0 22577 0 468079 0 0 0 THOMAS BOLS SVP/MANAGING DIRECTOR-EMEA 307200 0 0 0 0 0 17942 0 1534 0 326676 0 0 0 Carol Zhu SVP/Managing Director-China 242917 0 54911 0 0 0 0 0 13463 0 311291 0 0 0 TIM HESS GLOBAL IT DIRECTOR 197502 0 33993 0 0 0 11767 0 657 0 243919 0 0 0 ELISABETH SVENSSON SVP, MARKETING 274882 0 21998 0 0 0 15771 0 5518 0 318169 0 0 0 Ozgur Kara Associate Director, EMEA Finan 172510 0 7726 0 0 0 13674 0 1292 0 195202 0 0 0 Cathy Persidis Associate Director, EMEA Opera 151779 0 3602 0 0 0 9638 0 1647 0 166666 0 0 0 Akio Uemura SVP/Managing Director-Japan 150388 0 0 0 0 0 11098 0 0 0 161486 0 0 0 Alexander Eldridge IT Project Manager 146490 0 3230 0 0 0 8398 0 230 0 158348 0 0 0 NON-FIXED PAYMENTS SCHEDULE J, PART I, LINE 7 BONUSES ARE DISCRETIONARY AND BASED ON A VARIETY OF PARAMETERS THAT MEET THE GOALS OF THE ORGANIZATION. PROGRAM SERVICE ACCOMPLISHMENTS FORM 990, PART III LINE 4D DIA PROVIDES A PATIENT ADVOCATE FELLOWSHIP PROGRAM TO DEVELOP, STRENGTHEN, AND SUPPORT PATIENT COLLABORATIONS WITH POLICY MAKERS, INDUSTRY REPRESENTATIVES, PUBLIC HEALTH AUTHORITIES, ACADEMIA AND OTHER HEALTHCARE STAKEHOLDERS. INDIVIDUALS PARTICIPATING IN THIS PROGRAM ARE GIVEN COMPLIMENTARY REGISTRATION TO THE ANNUAL MEETING AND E-MEMBERSHIPS. MEMBERS OR STOCKHOLDERS FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS MEMBERS WHO PAY DUES BUT HAVE NO OWNERSHIP INTEREST IN THE ORGANIZATION. MEMBERS OR STOCKHOLDERS WHO MAY ELECT FORM 990, PART VI, SECTION A, LINE 7A EACH MEMBER IS ENTITLED TO ONE VOTE TO ELECT DIRECTORS, ONE VOTE TO ELECT OFFICERS AND ONE VOTE TO CHANGE THE BY-LAWS OF THE ORGANIZATION. SERVICE AS AN ELECTED OFFICER AND/OR BOARD DIRECTOR IS ON A VOLUNTARY BASIS. MEMBERS OR STOCKHOLDERS SUBJECT TO APPROVAL FORM 990, PART VI, SECTION A, LINE 7B EACH MEMBER OF THE BOARD (THE GOVERNING BODY) IS DULY ELECTED BY A PROXY VOTE OF THE MEMBERSHIP. THE ORGANIZATION'S BY-LAWS DEFINE THE DUTIES, RESPONSIBILITIES AND POWERS OF THE BOARD, INCLUDING THOSE ACTIONS SUBJECT TO MEMBERSHIP APPROVAL. FORM 990 REVIEW PROCESS FORM 990, PART VI, SECTION B, LINE 11B IRS FORM 990 IS PREPARED AND REVIEWED BY AN INTERNATIONAL ACCOUNTING FIRM. A DRAFT IS THEN JOINTLY REVIEWED BY THE EXECUTIVE DIRECTOR, THE CFO AND THE BOARD TREASURER/FINANCE COMMITTEE CHAIR. AFTER THIS REVIEW, A COMPLETE COPY OF THE FORM 990 IS PROVIDED TO THE BOARD PRIOR TO FILING WITH THE IRS. CONFLICT OF INTEREST POLICY MONITORING AND ENFORCEMENT FORM 990, PART VI, SECTION B, LINE 12C PERIODICALLY, MANAGEMENT EVALUATES ALL EXISTING PAID VENDOR RELATIONSHIPS FOR GOODS AND/OR SERVICES. THEY ASSESS THE PARTIES INVOLVED AND THE RELATIONSHIPS BETWEEN THEM AND DIA. WHERE CONFLICTS WITH STANDING POLICY MAY DEVELOP OR EXIST, APPROPRIATE CORRECTIVE ACTIONS ARE TAKEN, UP TO AND INCLUDING REPLACEMENT OF THE VENDOR WITH A SUITABLE AND QUALIFIED SUBSTITUTE THAT POSES NO CONFLICT OF INTEREST. NEW VENDORS ARE EVALUATED TO DETERMINE IF POTENTIAL CONFLICTS EXIST BEFORE APPROVAL OF ANY PAID RELATIONSHIP IS GRANTED. PROCESS USED TO DETERMINE EXECUTIVE COMPENSATION FORM 990, PART VI, SECTION B, LINES 15A & 15B ON A REGULAR BASIS, BUT NO LESS THAN BIENNIALLY, THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS EVALUATES THE COMPLETE COMPENSATION PACKAGES OF ALL UPPER MANAGEMENT LEVEL EMPLOYEES TO ENSURE THEY ARE COMPLIANT WITH ALL APPLICABLE LAWS AND CONSISTENT WITH THE PROVISIONS OF STANDING COMPENSATION POLICY. THIS INCLUDES SALARY, BENEFITS, BONUSES AND OTHER PAYMENTS MADE TO BOTH SENIOR MANAGEMENT AND ALL OTHERS DEEMED TO BE SUBJECT TO COMPENSATION REVIEW. THE COMPENSATION COMMITTEE OBTAINS AND RELIES UPON COMPARABLE DATA IN THE SAME OR SIMILAR COMMUNITIES FOR SIMILAR SERVICES. THE REVIEW PROCESS AND BASIS FOR COMPENSATION PACKAGES IS ADEQUATELY DOCUMENTED. THE RESULTS OF THE EVALUATION ARE PRESENTED TO THE BOARD OF DIRECTORS IN A FORMAL, WRITTEN COMPENSATION REPORT. HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S BYLAWS ARE AVAILABLE TO THE PUBLIC ON ITS WEBSITE. CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE NOT MADE AVAILABLE TO THE PUBLIC. OTHER CHANGES IN NET ASSETS & FUND BALANCES FORM 990, PART XI, LINE 9 INVESTMENTS IN SUBSIDIARIES $108,584 Patient Fellow Scholarship Grant 2,400 ------------ TOTAL $110,984 DRUG INFORMATION ASSOCIATION LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 237311318 Drug Edu PA 635 1335968 DIA Inc DIA GLOBAL HEALTHCARE LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 237311318 Drug Edu PA 10 449947 DIA Inc DIA LEARNING LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 475438125 Drug Edu PA 800686 1142543 DIA Inc DIA(INDIA) PRIVATE LIMITED UNIT 250 TIMES SQUAREANDHERI EAST Mumbai IN 400059 Scientific Ed IN DIA INC PRIVATE LTD 55655 46317 1.00000 true DIA EUROPE GMBH KUECHENGASSE 16 POSTAFACH Basel SZ 4002 Scientific Ed SZ DIA INC LLC 0 174886 1.00000 true DIA E-LEARNING EUROPE GMBH KUECHENGASSE 16 POSTAFACH Basel SZ 4002 Scientific Ed SZ DIA INC LLC 0 13479 1.00000 true DIA (BEIJING) HEALTHCARE INFORMATION GATEWAY PLAZA Beijing CH Scientific Ed CH DIA Global Hlth PRIVATE LLC 3305979 644446 1.00000 true SH DIA JAPAN NIHONBASHI LIFE SCI BLDG 6F Tokyo JA Scientific Ed JA DIA LLC GIC 1694135 3668044 1.00000 true DIA (SHANGHAI) HEALTHCARE INFORMATION SHANGHAI SHANGHAI CH SCIENTIFIC ED CH DIA GLOBAL HLTH PRIVATE LLC 1 4485 1.00000 true false true false false false false false false false false true true true false true false true true DIA India b 120000 cash